MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Type1 Diabetes MellitusDiabetes Mellitus, Type 1Autoimmune DiabetesJuvenile DiabetesDiabetes Mellitus ComplicationDiabetic NephropathiesMetabolic DiseaseDiabetic Kidney Disease
Interventions
DIAGNOSTIC_TEST

Blood draw

Participants will undergo a blood collection for hemoglobin A1c, adiponectin, total cholesterol, LDL, HDL, triglycerides, and c-peptide at baseline and follow up in 3-6 months.

DIAGNOSTIC_TEST

Urine sample collection

Participants will undergo urine sample collection for urine microalbumin and urine creatinine at baseline and follow up in 3-6 months.

DIAGNOSTIC_TEST

DXA scan

Participants will undergo a DXA scan for lean and fat mass measurements at baseline and follow up in 3-6 months.

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Colorado Clinical & Translational Sciences Institute

OTHER

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Colorado, Denver

OTHER

NCT03945747 - MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter